Research ArticleCancer

PTEN status determines chemosensitivity to proteasome inhibition in cholangiocarcinoma

See allHide authors and affiliations

Science Translational Medicine  23 Sep 2020:
Vol. 12, Issue 562, eaay0152
DOI: 10.1126/scitranslmed.aay0152

Article Information

vol. 12 no. 562

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication May 13, 2019
  • Resubmitted December 31, 2019
  • Accepted for publication July 28, 2020
  • .

Author Information

  1. Tian-Yi Jiang1,2,*,
  2. Yu-Fei Pan2,3,*,
  3. Zheng-Hua Wan2,*,
  4. Yun-Kai Lin1,2,
  5. Bin Zhu4,
  6. Zhen-gang Yuan4,
  7. Yun-Han Ma1,2,
  8. Yuan-Yuan Shi1,
  9. Tian-Mei Zeng4,
  10. Li-Wei Dong1,3,,
  11. Ye-Xiong Tan2,3, and
  12. Hong-Yang Wang1,2,3,5,6,
  1. 1International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, China.
  2. 2National Center for Liver Cancer, Shanghai 201805, China.
  3. 3Shanghai Key Laboratory of Hepato-biliary Tumor Biology, Shanghai 200438, China.
  4. 4Department of Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
  5. 5State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China.
  6. 6Laboratory of Signaling Regulation and Targeting Therapy of Liver Cancer, Second Military Medical University & Ministry of Education, Shanghai 200438, China.
  1. Corresponding author. Email: dlw{at}smmu.edu.cn (L.-W.D.); yxtan1214{at}163.com (Y.-X.T.); hywangk{at}vip.sina.com (H.-Y.W.)
  • * These authors contributed equally to this work.

Altmetric

Article usage

Article usage: September 2020 to January 2021

AbstractFullPdf
Sep 20204227909388
Oct 2020818170146
Nov 202033488132
Dec 2020169101123
Jan 20211278170

Stay Connected to Science Translational Medicine